RUSSELL FRANK CO/ - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 147 filers reported holding NEKTAR THERAPEUTICS in Q2 2014. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.

Quarter-by-quarter ownership
RUSSELL FRANK CO/ ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q1 2016$823,000
+32.3%
59,876
+65.0%
0.00%0.0%
Q4 2015$622,000
-2.2%
36,290
-28.6%
0.00%0.0%
Q2 2015$636,000
+3247.4%
50,800
+2904.1%
0.00%
Q1 2015$19,000
-99.0%
1,691
-98.6%
0.00%
-100.0%
Q4 2014$1,829,000
+135.7%
119,091
+85.2%
0.00%
+200.0%
Q3 2014$776,000
+42.4%
64,300
+26.6%
0.00%0.0%
Q2 2014$545,000
+51.0%
50,800
+47.1%
0.00%0.0%
Q3 2013$361,000
+27.6%
34,532
+40.8%
0.00%0.0%
Q2 2013$283,00024,5260.00%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q2 2014
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 432,952$1,385,0000.91%
GREAT POINT PARTNERS LLC 447,820$1,433,0000.34%
Birchview Capital, LP 128,000$410,0000.29%
Edgestream Partners, L.P. 1,047,636$3,352,0000.26%
Rhenman & Partners Asset Management AB 550,000$2,068,0000.22%
CM Management, LLC 50,000$160,0000.18%
TANG CAPITAL MANAGEMENT LLC 430,037$1,376,0000.17%
PDT Partners, LLC 307,953$985,0000.15%
Virtus ETF Advisers LLC 72,018$230,0000.09%
ALGERT GLOBAL LLC 476,412$1,525,0000.09%
View complete list of NEKTAR THERAPEUTICS shareholders